Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.47442 | 19 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.44606 | 19 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.44339 | 18 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.40349 | 19 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.38881 | 18 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.71554 | 28 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.44876 | 17 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.51079 | 22 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.41255 | 18 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.4301 | 18 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.42955 | 18 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.43405 | 19 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.43073 | 18 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.43631 | 18 |